Mohammad Erfan Zare , Atefeh Nasir Kansestani , Reza Meshkani , Kannan Vaidyanathan , Chao Qi , Guangwei Dai , Feng Zhao , Rui An , Jun Zhang
{"title":"Clinical laboratory directorship in Asia-Pacific and North America: Current practices and pathways to global framework development","authors":"Mohammad Erfan Zare , Atefeh Nasir Kansestani , Reza Meshkani , Kannan Vaidyanathan , Chao Qi , Guangwei Dai , Feng Zhao , Rui An , Jun Zhang","doi":"10.1016/j.cca.2025.120407","DOIUrl":null,"url":null,"abstract":"<div><div>Clinical laboratories are essential to modern healthcare, playing a critical role in diagnosing, monitoring, and managing diseases. Laboratory directors, as the highest authority in the laboratory, are responsible for overseeing operations, ensuring test accuracy, maintaining quality control, and safeguarding patient safety. These directors are highly qualified professionals, but the qualifications required for the role vary significantly across countries. In some countries, medical doctors (MDs) are the standard, while in others, non-MD clinical scientists are eligible for the position. This variation presents challenges, leading to ongoing discussions in scientific societies about the best pathways to prepare individuals for this critical role. This debate underscores the need to balance clinical expertise with specialized scientific knowledge to meet the evolving demands of laboratory medicine. To address these challenges, establishing a global common pathway for laboratory directorship qualifications is essential. Recognizing the diversity of qualification systems across countries is crucial for developing a pathway that can be globally adaptable and applicable to various healthcare contexts. Drawing inspiration from successful models around the world will be key in shaping such a framework. Europe, with its well-documented qualification frameworks, has made significant efforts toward harmonizing standards for laboratory directorship. However, data on qualification systems in regions like Asia-Pacific and North America remain limited. This review aims to evaluate the current qualification requirements in these regions, compare them to established models, and discuss the feasibility of creating a globally standardized pathway for laboratory director qualifications. The findings could serve as the foundation for developing a more detailed, common curriculum by international scientific societies such as the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), addressing the demands of various countries.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"576 ","pages":"Article 120407"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125002864","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Clinical laboratories are essential to modern healthcare, playing a critical role in diagnosing, monitoring, and managing diseases. Laboratory directors, as the highest authority in the laboratory, are responsible for overseeing operations, ensuring test accuracy, maintaining quality control, and safeguarding patient safety. These directors are highly qualified professionals, but the qualifications required for the role vary significantly across countries. In some countries, medical doctors (MDs) are the standard, while in others, non-MD clinical scientists are eligible for the position. This variation presents challenges, leading to ongoing discussions in scientific societies about the best pathways to prepare individuals for this critical role. This debate underscores the need to balance clinical expertise with specialized scientific knowledge to meet the evolving demands of laboratory medicine. To address these challenges, establishing a global common pathway for laboratory directorship qualifications is essential. Recognizing the diversity of qualification systems across countries is crucial for developing a pathway that can be globally adaptable and applicable to various healthcare contexts. Drawing inspiration from successful models around the world will be key in shaping such a framework. Europe, with its well-documented qualification frameworks, has made significant efforts toward harmonizing standards for laboratory directorship. However, data on qualification systems in regions like Asia-Pacific and North America remain limited. This review aims to evaluate the current qualification requirements in these regions, compare them to established models, and discuss the feasibility of creating a globally standardized pathway for laboratory director qualifications. The findings could serve as the foundation for developing a more detailed, common curriculum by international scientific societies such as the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), addressing the demands of various countries.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.